Protara Therapeutics logo

Protara Therapeutics share price today

(TARA)

Protara Therapeutics share price is $5.85 & ₹501.99 as on 7 Jan 2025, 2.30 'hrs' IST

$5.85

-0.29

(-4.72%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Protara Therapeutics share price in Dollar and Rupees. Guide to invest in Protara Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Protara Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Protara Therapeutics share price movements

  • Today's Low: $5.75
    Today's High: $6.18

    Day's Volatility :7.0%

  • 52 Weeks Low: $1.60
    52 Weeks High: $10.48

    52 Weeks Volatility :84.78%

Protara Therapeutics Returns

PeriodProtara Therapeutics IncIndex (Russel 2000)
3 Months
252.87%
0.0%
6 Months
188.26%
0.0%
1 Year
179.09%
0.0%
3 Years
-2.07%
-19.8%

Protara Therapeutics Key Statistics

in dollars & INR

Previous Close
$6.14
Open
$6.2
Today's High
$6.183
Today's Low
$5.75
Market Capitalization
$181.2M
Today's Volume
$563.2K
52 Week High
$10.48
52 Week Low
$1.595
Revenue TTM
$0.0
EBITDA
$-43.9M
Earnings Per Share (EPS)
$-2.64
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-45.91%

How to invest in Protara Therapeutics from India?

It is very easy for Indian residents to invest directly in Protara Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Protara Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Protara Therapeutics or TARA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Protara Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Protara Therapeutics shares which would translate to 0.147 fractional shares of Protara Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Protara Therapeutics, in just a few clicks!

Returns in Protara Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Protara Therapeutics investment value today

Current value as on today

₹2,69,132

Returns

₹1,69,132

(+169.13%)

Returns from Protara Therapeutics Stock

₹1,65,909 (+165.91%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Protara Therapeutics

-46%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Protara Therapeutics on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -46% less investors are searching Protara Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Protara Therapeutics

  • RA Capital Management, LLC

    9.21%

  • Opaleye Management Inc

    8.15%

  • StemPoint Capital LP

    4.57%

  • Woodline Partners LP

    4.13%

  • Boxer Capital LLC

    3.93%

  • Vanguard Group Inc

    3.68%

Analyst Recommendation on Protara Therapeutics

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Protara Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Protara Therapeutics

What analysts predicted

Upside of 351.28%

Current:

$5.85

Target:

$26.40

Insights on Protara Therapeutics

  • Price Movement

    In the last 7 days, TARA stock has moved up by 16.3%
  • TARA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 56.2%

Protara Therapeutics Technicals Summary

Sell

Neutral

Buy

Protara Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Protara Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Protara Therapeutics Inc
-7.95%
188.26%
179.09%
-2.07%
-79.53%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Protara Therapeutics Inc
NA
NA
NA
-2.33
-0.46
-0.28
NA
6.01
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Protara Therapeutics Inc
Buy
$181.2M
-79.53%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Protara Therapeutics

protara therapeutics, inc., a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases. the company's lead program is tara-002, an investigational cell therapy for the treatment of lymphatic malformations. it also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. the company was formerly known as artara therapeutics, inc. and changed its name to protara therapeutics, inc. in may 2020. protara therapeutics, inc. is based in new york, new york.
Organization
Protara Therapeutics
Employees
26
CEO
Mr. Jesse Shefferman
Industry
Health Technology

Management People of Protara Therapeutics

NameTitle
Mr. Jesse Shefferman
Co-founder, CEO, President & Director
Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D.
Co-Founder, Senior VP & Chief Scientific Operations Officer
Mr. Patrick Fabbio M.B.A.
Chief Financial Officer
Ms. Hannah Fry
VP, Principal Accounting Officer & Controller
Ms. Justine O'Malley
Senior Vice President of Investor Relations & Corporate Affairs

Important FAQs about investing in Protara Therapeutics from India :

What is Protara Therapeutics share price today?

Protara Therapeutics share price today stands at $5.85, Open: $6.20 ; Previous Close: $6.14 ; High: $6.18 ; Low: $5.75 ; 52 Week High: $10.48 ; 52 Week Low: $1.60. The stock opens at $6.20, after a previous close of $6.14. The stock reached a daily high of $6.18 and a low of $5.75, with a 52-week high of $10.48 and a 52-week low of $1.60.

Can Indians buy Protara Therapeutics shares?

Yes, Indians can invest in the Protara Therapeutics (TARA) from India.

With INDmoney, you can buy Protara Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Protara Therapeutics at zero transaction cost.

How can I buy Protara Therapeutics shares from India?

It is very easy to buy Protara Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Protara Therapeutics be purchased?

Yes, you can buy fractional shares of Protara Therapeutics with INDmoney app.

What are the documents required to start investing in Protara Therapeutics stocks?

To start investing in Protara Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Protara Therapeutics

Today’s highest price of Protara Therapeutics (TARA) is $6.18.

Today’s lowest price of Protara Therapeutics (TARA) is $5.75.

What is today's market capitalisation of Protara Therapeutics

Today's market capitalisation of Protara Therapeutics TARA is 181.2M

What is the 52 Week High and Low Range of Protara Therapeutics

  • 52 Week High

    $10.48

  • 52 Week Low

    $1.60

What are the historical returns of Protara Therapeutics?

  • 1 Month Returns

    -7.95%

  • 3 Months Returns

    188.26%

  • 1 Year Returns

    179.09%

  • 5 Years Returns

    -79.53%

Who is the Chief Executive Officer (CEO) of Protara Therapeutics

Mr. Jesse Shefferman is the current Chief Executive Officer (CEO) of Protara Therapeutics.